Industry
Sinha diary: Bhushan tells SC he won’t disclose source
18 Sep 2014
Lawyer Prashant Bhushan, who has filed a public interest suit against CBI director Ranjit Sinha, today refused a Supreme Court directive to reveal the name of the whistleblower who provided him with Sinha’s residential guest book
TV still leads India’s entertainment & media industry, but internet growth faster
17 Sep 2014
Internet access and internet advertising have been the fastest-growing segments, with annual growth rates of 47 per cent and 26 per cent respectively.
TV still leads India’s entertainment & media industry, but internet growth faster
17 Sep 2014
Internet access and internet advertising have been the fastest-growing segments, with annual growth rates of 47 per cent and 26 per cent respectively.
TUI Travel to merge with parent to create £5.2-bn tourism giant
16 Sep 2014
The merger would see TUI Travel, which serves 30 million customers join TUI AG, owner of 230 hotels and seven cruise ships
Oil ministry extends deadline for comments on draft revenue sharing model till 20 September
15 Sep 2014
Real estate transactions go online
15 Sep 2014
In the last couple of years, real estate sector has seen the emergence of websites as a low-cost tool to connect buyers and sellers. By Advitiya Sharma, co-founder and marketing head, housing.com
China creates special smartphone lanes for pedestrians to prevent them from bumping into each other
15 Sep 2014
Reveal source of ‘Sinha diaries’, SC tells Prashant Bhushan
15 Sep 2014
CBI director Ranjit Sinha has consistently maintained that the log of visitors at his residence provided by activist Supreme Court lawyer Prashant Bhushan to the SC is a forgery, with 90 per cent of the entries forged
US judge upholds Ranbaxy-Pfizer Lipitor marketing deal
13 Sep 2014
In a piece of good news for the US FDA-challenged Ranbaxy laboratories, a US court has dismissed an anti-trust suit against Pfizer Inc and India's Ranbaxy that accused them of conspiring to delay sales of generic versions of the cholesterol drug Lipitor
US judge upholds Ranbaxy-Pfizer Lipitor marketing deal
13 Sep 2014
In a piece of good news for the US FDA-challenged Ranbaxy laboratories, a US court has dismissed an anti-trust suit against Pfizer Inc and India's Ranbaxy that accused them of conspiring to delay sales of generic versions of the cholesterol drug Lipitor
Coalgate: SC refuses to reopen hearing for power companies
12 Sep 2014
With the centre advocating cancellation of the coal blocks awarded illegally, companies have blamed the government for irregularities and demanded the setting up of a committee to go into each of the allocations
Latest articles
Featured articles
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
